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Abstract  
 
Background: In 1992, the ICD-10 introduced the concept of mixed anxiety–depression disorder 
(MAD). However, a study examining the stability of this ICD-10-diagnosis is lacking. Our objective 
was to examine the 12 month outcome of MAD in comparison to the outcome of depression, anxiety, 
and comorbid depression and anxiety. Methods: 85 MAD patients, 496 patients with major depression, 
296 patients with anxiety disorders, and 306 comorbid patients were reassessed after 12 months. Rates 
of depression, anxiety, and MAD were compared using χ2-tests. Results: While depressive disorders 
and anxiety disorders showed relatively high stability, MAD Patients had no higher rates of MAD at 
follow-up than patients with depression, anxiety or both. Limitations: Detailed information regarding 
treatment and disorders during the follow-up interval was lacking. Prevalence rates of MAD in single 
centres were too small for contrasting centres. Conclusions: MAD cannot be seen as a stable 
diagnosis: Most of MAD patients remit; many of them shift to other diagnoses than depression or 
anxiety. The ICD-10 criteria have to be specified more exactly.   
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1. Introduction  
 
A substantial number of patients suffer from depressive and anxiety symptoms without 
meeting official criteria of either ICD-10 or DSM-IV depressive and/or anxiety disorders 
(Zinbarg et al., 1994; Stein et al., 1995; see Katon and Roy-Byrne, 1991; Wittchen and Essau, 
1993; Boulenger et al., 1997 for reviews). These patients are frequent in primary care (Barrett 
et al., 1988; Wittchen and Essau, 1993; Barlow and Campbell, 2000). To provide a clinical 
definition for those patients the ICD-10 (WHO, 1992) introduced the concept of mixed 
anxiety–depression disorder (MAD). The criteria for MAD are as follows:  
 
1. Presence of mild or moderate anxiety and depression, without prevailing of anxiety or 
depression,  
2. at least temporary occurrence of vegetative symptoms,  
3. the symptoms do not fulfil the criteria of an anxiety disorder or a depressive episode.  
 
The status of the ICD-10-MAD diagnosis — in relation to depressive and anxiety disorders — 
needs further research. There is a need for follow-up studies — explicitly applying the 
specified diagnostic criteria of the ICD-10 — to determine the temporal stability of a given 
ICD-10-MAD diagnosis and the possible shift to depressive and/or anxiety disorders (see also 
Katon and Roy-Byrne, 1991; Wittchen and Essau, 1993; Stein et al., 1995). This study 
examines the outcome of a given ICD-10-MAD diagnosis as compared to depression and 
anxiety after one year in a primary care sample in terms of the diagnostic status. Data were 
collected within the scope of the World Health Organization (WHO) Collaborative Study on 
‘Psychological Problems in General Health Care’, which is a cross-sectional and prospective-
longitudinal international study (Sartorius et al., 1993; Üstün and Sartorius, 1995).  
 
2. Methods  
 
From the sample of the WHO Collaborative Study1 patients meeting ICD-10 criteria for a 
depressive episode, dysthymia, agoraphobia, panic disorder, generalised anxiety disorder 
(GAD), comorbid depressive and anxiety disorder, and MAD at the baseline assessment were 
identified and reassessed after 12 months. Additional ICD-10 psychiatric diagnoses were 
allowed. Patients older than 65 years were excluded. ICD-10 diagnoses were obtained using 
the Composite International Diagnostic Interview- Primary Health Care Version (CIDI-PHC), 
a modification of the Composite International Diagnostic Interview (CIDI; Division of Mental 
Health, 1990). The interviewer–observer reliability coefficient (across different centres) of the 
CIDI-PHC was 0.92 overall, ranging between 0.81 to 1.0 on the item level. For this 
coefficient a total of 19 videotaped interviews were circulated between the centres.  
 
For the statistical analysis, single diagnoses were combined to depressive disorders, anxiety 
disorders, comorbid depressive and anxiety disorder, and MAD. Frequency analyses were 
conducted using SPSS (SPSS Inc, Chicago, Ill). Single comparisons within the whole 
contingency table were carried out (Jesdinsky, 1968). Presence of the diagnosis under 
examination was tested against absence (i.e. combined possible outcome categories). The 
significance level was always set at 1- sided P<0.05. It was corrected for multiple testing 
applying the Bonferoni-procedure if necessary.  
 
3. Results  
 
3.1. Sample characteristics  
 
A total of 1856 patients were identified to meet ICD- 10 criteria for a depressive episode, 
dysthymia, agoraphobia, panic disorder, GAD, comorbid anxiety and depressive disorder, and 
MAD at the baseline diagnostic assessment. 1183 subjects (63.7%) could be re-examined at 
the follow-up. A total of 673 (36.3%) did not participate in the follow-up examination 
because they had moved and were not found anymore, because of refusal or because of death. 
Exact proportions were not recorded. There was no significant difference between participants 
and non-participants regarding sex (participants: proportion female=73.1%, non-participants: 
proportion female=72.5%; χ2=0.80, df =1, P=0.777), and statistically significant but slight 
differences regarding age (participants’ mean age= 39.67, non-participants’ mean age=40.95; 
t =-2.025, df =1854, P=0.043). The study sample of the baseline assessment is described in 
Table 1.  
 
3.2. Twelve month outcome  
 
MAD, depressive episodes, dysthymia, agoraphobia, panic disorder only, GAD, and comorbid 
depressive and anxiety disorder showed a substantial improvement (average remission rate: 
41.9%). 16.7% of all patients had exactly the same ICD- 10-diagnosis at both assessments 
with MAD showing the lowest rate of stable diagnoses (1.2%). The majority of MAD patients 
remitted or shifted to other (non-depressive and non-anxiety) diagnoses (see Table 2).  
 
Table 2 shows the 12 month outcome of combined diagnoses. As was expected, follow-up 
rates of depressive disorders were higher in patients with depression and comorbid patients at 
baseline as compared to patients with an anxiety disorder at baseline (χ2 = 8.84, df =1, P < 
0.01; χ2 = 6.00, df =1, P< 0.05, respectively). Follow-up rates of anxiety disorders were 
higher in patients with an anxiety disorder and comorbid patients at baseline as compared to 
patients with a depressive disorder at baseline (χ2=21.71, df =1, P<0.001; χ2 =13.25, df =1, P 
< 0.001, respectively). There were no differences regarding follow-up depression rates 
between patients with a depressive disorder and comorbid patients [χ2 = 0.01, df =1, not 
significant (n.s.)] and no significant differences regarding follow-up anxiety rates between 
patients with an anxiety disorder and comorbid patients at baseline (χ2 = 0.9065, df =1, n.s.).  
 
There were no differences regarding follow-up MAD rates between patients with MAD and 
those with a depressive disorder (χ2 = 0.92, df=1, n.s.), those with an anxiety disorder (χ2 = 
0.09, df =1, n.s.), and those with comorbid depression–anxiety at baseline (χ2 = 0.38, df =1, 
n.s.).  
 
Follow-up rates of depressive disorders were not significantly lower in patients with MAD as 
compared to patients with a depressive disorder at baseline (χ2 = 2.00, df =1, n.s.) and to 
those with comorbid depression–anxiety at baseline (χ2 = 1.45, df =1, n.s.) although there was 
a trend in the expected direction.  
 
Follow-up rates of anxiety disorders were not significantly lower in patients with MAD as 
compared to those with an anxiety disorder at baseline (χ2 = 5.07, df =1, n.s.) and to those 
with comorbid depression– anxiety at baseline (χ2 = 2.65, df =1, n.s.), although a trend in this 
direction is obvious.  
 
4. Discussion  
 
The data presented herein did not show temporal stability of MAD as compared to depressive 
and anxiety disorders. Our results are in contrast to the findings of Usall and Marquez (1999) 
who concluded that MAD is a stable diagnosis. These authors applied DSM-IV research 
criteria so that their results cannot be directly compared with our findings.  
 
4.1. Implications  
 
ICD-10 MAD criteria are relatively vague compared to DSM-IV research criteria (APA, 
1994) clearly specifying symptoms necessary for the MAD diagnosis. Although ICD-10 and 
DSM-IV are similar regarding organisation, designations of disorders, abandonment of 
theoretical disease concepts, and criteria based diagnostics there are important differences 
regarding single diagnoses, partly due to the fact that the DSM-IV was developed for the USA 
while the ICD-10 serves as a guideline for diagnostics worldwide leading to more 
compromises in the ICD-10.  
 
A revision of the ICD-10 MAD diagnosis seems necessary. For such a revision several 
possibilities are conceivable: Preskorn and Fast (1993) argue against a MAD diagnosis and 
are in favour of a careful psychiatric assessment resulting in either depression or anxiety 
diagnoses. Others proposed a non-specific negative affect as common diathesis for anxiety 
and depression (Clark and Watson, 1991; Barlow and Campbell, 2000), which would have 
extensive consequences for the diagnostic manuals. The results presented herein do not allow 
for statements about the relationship between anxiety, depression and MAD. Therefore, future 
research is necessary.  
 
Either way, the present study shows that an assiduous psychiatric assessment incorporating 
longitudinal information (i.e., medical history and follow-up assessments) is indispensable. Of 
course, the question arises whether the ICD-10 classification lives up to rather minor 
disorders frequently seen in primary care and whether an appropriate ICD-10 diagnosis 
suffices. [Also other diagnoses assessed herein changed diagnostic category relatively 
frequently (Table 2)]. Especially in minor disorders, where psychotherapeutical approaches 
play an important role, the formulation of an individual disease model and an according 
treatment is much more determining.  
 
4.2. Limitations  
 
Depressive and anxiety disorders might be more severe disorders than MAD, therefore, more 
easily remitting. Nevertheless, the remission rates for the other disorders were also quite high. 
Moreover, GAD which also can be seen as relatively mild psychiatric condition shows a high 
degree of chronicity (Mancuso et al., 1993; Schweizer, 1995; Woodman et al., 1999).  
 
Prevalence rates of MAD in single centres were to small for contrasting outcomes of this 
diagnosis between different centres so that probable socio-cultural differences are not shown.  
 
One might speculate that the exclusion of elderly patients resulted in an overestimation of 
instability of MAD: The more unknown and shorter medical history in younger patients 
probably leads to more diagnoses of MAD that might in turn be revised after a certain time 
span. In older patients with longer illness histories a MAD diagnosis might not be so easily 
corrected. On the other hand, the frequency of MAD might decline in the elderly for the same 
reasons.  
 
Other limitations are lacking information regarding treatment and remissions and relapses 
during the follow-up.  
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